Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Titel:
Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Auteur:
Abaza, Yasmin Hidalgo-Lopez, Juliana E. Verstovsek, Srdan Jabbour, Elias Ravandi, Farhad Borthakur, Gautam Estrov, Zeev Alvarado, Yesid Burger, Jan Schneider, Heather Soltysiak, Kelly A. Wei, Yue Kantarjian, Hagop M. Bueso-Ramos, Carlos E. Garcia-Manero, Guillermo